Erudio Healtherudio.com
Drug
Tocilizumab trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying tocilizumab: MORPHEUS-panBC. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 10 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| MORPHEUS-panBC NCT03424005 · Hoffmann-La Roche | metastatic breast cancer | Phase 1/Phase 2 | 7 | 4 | Focused | Nov 20, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| ZUMA-1 NCT02348216 · Kite, A Gilead Company DeepView → | refractory large B-cell lymphoma | Phase 1/Phase 2 | Deep | View | |||
| STARGLO NCT04408638 · Hoffmann-La Roche DeepView → | relapsed/refractory diffuse large B-cell lymphoma | Phase 3 | Deep | View | |||
| SUNMO NCT05171647 · Hoffmann-La Roche DeepView → | transplant-ineligible relapsed/refractory large B-cell lymphoma | Phase 3 | Deep | View | |||
| MorningSun NCT05207670 · Genentech, Inc. DeepView → | non-Hodgkin lymphoma | Phase 2 | Deep | View | |||
| NP30179 NCT03075696 · Hoffmann-La Roche DeepView → | relapsed/refractory B-cell non-Hodgkin lymphoma | Phase 1/Phase 2 | Deep | View | |||
| MORPHEUS-UC NCT03869190 · Hoffmann-La Roche StandardView → | urothelial carcinoma | Phase 1/Phase 2 | Standard | View | |||
| NCT03671018 NCT03671018 · Hoffmann-La Roche FocusedView → | relapsed or refractory B-cell non-Hodgkin lymphoma | Phase 1/Phase 2 | Focused | View | |||
| NCT03677141 NCT03677141 · Hoffmann-La Roche FocusedView → | Not given | Phase 1/Phase 2 | Focused | View | |||
| PACTO NCT02767557 · Herlev Hospital FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT03275103 NCT03275103 · Genentech, Inc. FocusedView → | Not given | Phase 1 | Focused | View | |||